Feasibility of neoadjuvant and adjuvant intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer: A single-center experience

Intraperitoneal (IP) chemotherapy is believed to prolong the survival of patients with advanced ovarian cancer after primary debulking surgery. However, there is little knowledge about IP chemotherapy in the setting of neoadjuvant chemotherapy, and there are contradictory conclusions about adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu, Cao, Lili, Chen, Wei, Wang, Jingjing, Wang, Wenting, Liang, Zhiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478764/
https://www.ncbi.nlm.nih.gov/pubmed/32899091
http://dx.doi.org/10.1097/MD.0000000000022100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478764/
https://www.ncbi.nlm.nih.gov/pubmed/32899091
http://dx.doi.org/10.1097/MD.0000000000022100

Ejemplares similares